KRT35
gene geneOn this page
Also known as Ha-5
Summary
KRT35 (keratin 35, HGNC:6453) is a protein-coding gene on chromosome 17q21.2, encoding Keratin, type I cuticular Ha5 (Q92764).
The protein encoded by this gene is a member of the keratin gene family. This type I hair keratin is an acidic protein which heterodimerizes with type II keratins to form hair and nails. The type I hair keratins are clustered in a region of chromosome 17q12-q21 and have the same direction of transcription.
Source: NCBI Gene 3886 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 89 total
- MANE Select transcript:
NM_002280
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:6453 |
| Approved symbol | KRT35 |
| Name | keratin 35 |
| Location | 17q21.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | Ha-5 |
| Ensembl gene | ENSG00000197079 |
| Ensembl biotype | protein_coding |
| OMIM | 602764 |
| Entrez | 3886 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000246639
RefSeq mRNA: 1 — MANE Select: NM_002280
NM_002280
CCDS: CCDS11394
Canonical transcript exons
ENST00000246639 — 7 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001118283 | 41476710 | 41477203 |
| ENSE00001118291 | 41480627 | 41481151 |
| ENSE00002359606 | 41477518 | 41477738 |
| ENSE00002360867 | 41478834 | 41478995 |
| ENSE00002367417 | 41478361 | 41478486 |
| ENSE00002409689 | 41479347 | 41479503 |
| ENSE00002420924 | 41479699 | 41479781 |
Expression profiles
Bgee: expression breadth broad, 44 present calls, max score 74.51.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0069 / max 9.4684, expressed in 3 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 165903 | 0.0069 | 3 |
Top tissues by expression
262 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| upper arm skin | UBERON:0004263 | 74.51 | silver quality |
| hair follicle | UBERON:0002073 | 67.32 | gold quality |
| decidua | UBERON:0002450 | 56.55 | gold quality |
| gluteal muscle | UBERON:0002000 | 56.34 | gold quality |
| triceps brachii | UBERON:0001509 | 56.25 | gold quality |
| zone of skin | UBERON:0000014 | 53.71 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 53.67 | gold quality |
| skin of leg | UBERON:0001511 | 52.46 | gold quality |
| endometrium epithelium | UBERON:0004811 | 52.42 | gold quality |
| tibialis anterior | UBERON:0001385 | 51.43 | silver quality |
| deltoid | UBERON:0001476 | 50.76 | gold quality |
| nipple | UBERON:0002030 | 50.50 | gold quality |
| frontal pole | UBERON:0002795 | 50.41 | gold quality |
| middle frontal gyrus | UBERON:0002702 | 50.30 | gold quality |
| quadriceps femoris | UBERON:0001377 | 50.29 | gold quality |
| paraflocculus | UBERON:0005351 | 50.18 | gold quality |
| Brodmann (1909) area 10 | UBERON:0013541 | 50.18 | gold quality |
| skin of abdomen | UBERON:0001416 | 50.15 | gold quality |
| vastus lateralis | UBERON:0001379 | 49.35 | gold quality |
| Brodmann (1909) area 46 | UBERON:0006483 | 49.30 | gold quality |
| blood vessel layer | UBERON:0004797 | 49.29 | gold quality |
| cerebellar vermis | UBERON:0004720 | 49.25 | gold quality |
| cervix squamous epithelium | UBERON:0006922 | 49.20 | gold quality |
| thymus | UBERON:0002370 | 48.95 | gold quality |
| olfactory bulb | UBERON:0002264 | 48.92 | gold quality |
| choroid plexus epithelium | UBERON:0003911 | 48.89 | gold quality |
| myocardium | UBERON:0002349 | 48.87 | gold quality |
| type B pancreatic cell | CL:0000169 | 48.83 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 48.72 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 48.55 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.14 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): RELA
miRNA regulators (miRDB)
13 targeting KRT35, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-205-3P | 99.92 | 69.92 | 3165 |
| HSA-MIR-3065-3P | 99.87 | 70.25 | 1407 |
| HSA-MIR-3942-3P | 99.57 | 69.03 | 2854 |
| HSA-MIR-203A-3P | 99.49 | 70.56 | 2806 |
| HSA-MIR-217-5P | 99.49 | 69.93 | 1419 |
| HSA-MIR-4251 | 99.40 | 69.19 | 3363 |
| HSA-MIR-4727-5P | 99.23 | 67.55 | 1154 |
| HSA-MIR-6807-3P | 99.15 | 69.23 | 1275 |
| HSA-MIR-4253 | 97.48 | 65.11 | 692 |
| HSA-MIR-6862-5P | 97.48 | 64.84 | 713 |
| HSA-MIR-2909 | 96.36 | 67.30 | 562 |
| HSA-MIR-4761-3P | 96.27 | 66.26 | 524 |
| HSA-MIR-769-5P | 94.45 | 64.56 | 603 |
Literature-anchored findings (GeneRIF, showing 2)
- the co-expression of hair keratin hHa5 with its regulatory nuclear homeoprotein HOXC13 in matrix cells of the hair follicle is maintained in lower transitional cells of pilomatricomas (PMID:15140206)
- p65 induces transcriptional activation of Ha5. It is co-expressed with it & may mediate the NF-kappaB pathway’s activity. There are major NF-kappaB/RelA binding sites in its regulatory region; p65 binds directly to these sites. (PMID:18021261)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Krt35 | ENSMUSG00000048013 |
| rattus_norvegicus | Krt35 | ENSRNOG00000013754 |
Paralogs (68): KRT33A (ENSG00000006059), VIM (ENSG00000026025), KRT31 (ENSG00000094796), NEFM (ENSG00000104722), KRT23 (ENSG00000108244), KRT37 (ENSG00000108417), KRT32 (ENSG00000108759), KRT18 (ENSG00000111057), LMNB1 (ENSG00000113368), KRT36 (ENSG00000126337), KRT17 (ENSG00000128422), GFAP (ENSG00000131095), KRT34 (ENSG00000131737), KRT33B (ENSG00000131738), NES (ENSG00000132688), PRPH (ENSG00000135406), KRT85 (ENSG00000135443), KRT7 (ENSG00000135480), KRT71 (ENSG00000139648), INA (ENSG00000148798), LMNTD1 (ENSG00000152936), LMNA (ENSG00000160789), KRT84 (ENSG00000161849), KRT82 (ENSG00000161850), KRT80 (ENSG00000167767), KRT1 (ENSG00000167768), KRT24 (ENSG00000167916), KRT8 (ENSG00000170421), KRT78 (ENSG00000170423), KRT86 (ENSG00000170442), KRT75 (ENSG00000170454), KRT6C (ENSG00000170465), KRT4 (ENSG00000170477), KRT74 (ENSG00000170484), KRT72 (ENSG00000170486), KRT83 (ENSG00000170523), BFSP2 (ENSG00000170819), KRT19 (ENSG00000171345), KRT15 (ENSG00000171346), KRT38 (ENSG00000171360)
Protein
Protein identifiers
Keratin, type I cuticular Ha5 — Q92764 (reviewed: Q92764)
Alternative names: Hair keratin, type I Ha5, Keratin-35
All UniProt accessions (2): C4AM86, Q92764
UniProt curated annotations — full annotation on UniProt →
Tissue specificity. Early expression in the hair follicle, mainly found in supramatricial cells and lowermost cortical cells of the hair bulb.
Miscellaneous. There are two types of hair/microfibrillar keratin, I (acidic) and II (neutral to basic).
Similarity. Belongs to the intermediate filament family.
RefSeq proteins (1): NP_002271* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR002957 | Keratin_I | Family |
| IPR018039 | IF_conserved | Conserved_site |
| IPR039008 | IF_rod_dom | Domain |
Pfam: PF00038
UniProt features (14 total): region of interest 7, sequence variant 3, chain 1, domain 1, sequence conflict 1, site 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q92764-F1 | 76.57 | 0.57 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Catalytic / active sites (1): 346 (stutter)
Function
Pathways and Gene Ontology
Reactome pathways
3 pathways
| ID | Pathway |
|---|---|
| R-HSA-6805567 | Keratinization |
| R-HSA-6809371 | Formation of the cornified envelope |
| R-HSA-1266738 | Developmental Biology |
MSigDB gene sets: 80 (showing top):
GOBP_MORPHOGENESIS_OF_AN_EPITHELIUM, GOBP_EPITHELIUM_DEVELOPMENT, GOBP_INTERMEDIATE_FILAMENT_BASED_PROCESS, GOBP_INTERMEDIATE_FILAMENT_ORGANIZATION, GCM_MYCL1, GCM_RING1, CATTTCA_MIR203, MARTINEZ_RB1_TARGETS_DN, MODULE_298, TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA, AACTTT_UNKNOWN, GCM_ATM, MODULE_20, GOBP_TISSUE_MORPHOGENESIS, GCM_LTK
GO Biological Process (4): morphogenesis of an epithelium (GO:0002009), anatomical structure morphogenesis (GO:0009653), epithelial cell differentiation (GO:0030855), intermediate filament organization (GO:0045109)
GO Molecular Function (3): structural constituent of skin epidermis (GO:0030280), structural molecule activity (GO:0005198), protein binding (GO:0005515)
GO Cellular Component (6): obsolete extracellular space (GO:0005615), cytosol (GO:0005829), cytoskeleton (GO:0005856), keratin filament (GO:0045095), extracellular exosome (GO:0070062), intermediate filament (GO:0005882)
Reactome top-level categories
Rollup of top-2 pathways:
| Category | Pathways |
|---|---|
| Developmental Biology | 1 |
| Keratinization | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| epithelium development | 2 |
| tissue morphogenesis | 1 |
| developmental process | 1 |
| anatomical structure development | 1 |
| cell differentiation | 1 |
| intermediate filament cytoskeleton organization | 1 |
| supramolecular fiber organization | 1 |
| structural molecule activity | 1 |
| molecular_function | 1 |
| binding | 1 |
| cytoplasm | 1 |
| cellular anatomical structure | 1 |
| intracellular membraneless organelle | 1 |
| intermediate filament | 1 |
| extracellular vesicle | 1 |
| intermediate filament cytoskeleton | 1 |
| polymeric cytoskeletal fiber | 1 |
Protein interactions and networks
STRING
872 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| KRT35 | KRT85 | P78386 | 732 |
| KRT35 | MYO1G | B0I1T2 | 595 |
| KRT35 | HOXC13 | P31276 | 593 |
| KRT35 | KRTAP11-1 | Q8IUC1 | 570 |
| KRT35 | CA5A | P35218 | 549 |
| KRT35 | KRTAP3-1 | Q9BYR8 | 543 |
| KRT35 | CA6 | P23280 | 507 |
| KRT35 | CD1A | P06126 | 487 |
| KRT35 | HTATIP2 | Q9BUP3 | 480 |
| KRT35 | DSG4 | Q86SJ6 | 442 |
| KRT35 | HOXC12 | P31275 | 441 |
| KRT35 | KRT18 | P05783 | 439 |
| KRT35 | ARHGAP45 | Q92619 | 430 |
| KRT35 | CA4 | P22748 | 426 |
| KRT35 | TCHH | Q07283 | 412 |
IntAct
273 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| KRT78 | KRT35 | psi-mi:“MI:0915”(physical association) | 0.630 |
| TRIM29 | KRT35 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRT6A | KRT35 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRT4 | KRT35 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MYO15B | KRT35 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SMYD1 | KRT35 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PKN1 | KRT35 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRT35 | MCRS1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| C21orf58 | KRT35 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRT77 | KRT35 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRT35 | TAPBPL | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRT35 | CTSZ | psi-mi:“MI:0915”(physical association) | 0.560 |
| OIP5 | KRT35 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRT35 | AIRIM | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRT35 | TEPSIN | psi-mi:“MI:0915”(physical association) | 0.560 |
| CCHCR1 | KRT35 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRT35 | HAPLN2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TCEANC | KRT35 | psi-mi:“MI:0915”(physical association) | 0.560 |
| HGS | KRT35 | psi-mi:“MI:0915”(physical association) | 0.560 |
| EFCAB3 | KRT35 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRT35 | PRPF18 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRT2 | KRT35 | psi-mi:“MI:0915”(physical association) | 0.560 |
| HOXC8 | KRT35 | psi-mi:“MI:0915”(physical association) | 0.560 |
| UBASH3A | KRT35 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ATG9A | KRT35 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRT86 | KRT35 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRT35 | ZNF446 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRT83 | KRT35 | psi-mi:“MI:0915”(physical association) | 0.560 |
| HCK | KRT35 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRT35 | VPS9D1 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (108): KRT35 (Affinity Capture-MS), KRT35 (Affinity Capture-MS), KRT35 (Affinity Capture-MS), KRT35 (Two-hybrid), KRT35 (Two-hybrid), KRT35 (Two-hybrid), KRT35 (Two-hybrid), KRT35 (Two-hybrid), KRT35 (Two-hybrid), KRT35 (Two-hybrid), KRT35 (Two-hybrid), KRT35 (Two-hybrid), KRT35 (Two-hybrid), KRT35 (Two-hybrid), KRT35 (Two-hybrid)
ESM2 similar proteins: A1L317, A1L595, A5A6N2, A6BLY7, B1AQ75, E1AB55, O76013, P02533, P08730, P08779, P13646, P19012, Q0P5J4, Q0P5J6, Q0P5J7, Q148H5, Q148H6, Q148H8, Q2M2I5, Q3UV17, Q497I4, Q61414, Q61781, Q64291, Q6IFU7, Q6IFU8, Q6IFV1, Q6IFV3, Q6IFV4, Q6IFW6, Q6IFW8, Q6IFX0, Q6IFX1, Q6IFX2, Q6NXH9, Q6R649, Q6R650, Q7Z3Y7, Q7Z3Y8, Q7Z3Y9
Diamond homologs: A1KQY9, A1L317, A1L595, A5A6M0, A5A6M5, A5A6N2, A5A6P3, A6BLY7, A6QQQ9, A7YWM2, B0LKP1, B1AQ75, O57607, O57611, O76009, O76013, O77727, O93256, P02533, P02534, P02535, P02537, P05781, P05783, P05784, P06394, P08727, P08728, P08730, P08777, P08778, P08779, P08802, P13645, P13646, P19001, P19012, P25030, P25690, P35527
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 90 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Formation of the cornified envelope | 22 | 32.8× | 4e-26 |
| Keratinization | 22 | 20.8× | 7e-22 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| intermediate filament organization | 21 | 64.0× | 9e-31 |
| keratinization | 21 | 62.2× | 9e-31 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
89 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 81 |
| Likely benign | 8 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
515 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 17:41477509:GATAC:G | donor_loss | 1.0000 |
| 17:41477510:ATACT:A | donor_loss | 1.0000 |
| 17:41477513:CTCA:C | donor_gain | 1.0000 |
| 17:41477514:TCA:T | donor_loss | 1.0000 |
| 17:41477515:CA:C | donor_loss | 1.0000 |
| 17:41477516:A:AC | donor_gain | 1.0000 |
| 17:41477516:ACTTG:A | donor_gain | 1.0000 |
| 17:41477517:C:A | donor_loss | 1.0000 |
| 17:41477517:C:CC | donor_gain | 1.0000 |
| 17:41477517:CT:C | donor_gain | 1.0000 |
| 17:41477517:CTT:C | donor_gain | 1.0000 |
| 17:41477517:CTTG:C | donor_gain | 1.0000 |
| 17:41477517:CTTGC:C | donor_gain | 1.0000 |
| 17:41477735:CTCT:C | acceptor_gain | 1.0000 |
| 17:41477737:CT:C | acceptor_gain | 1.0000 |
| 17:41477749:A:T | acceptor_gain | 1.0000 |
| 17:41477754:T:C | acceptor_gain | 1.0000 |
| 17:41477754:T:TC | acceptor_gain | 1.0000 |
| 17:41477756:G:C | acceptor_gain | 1.0000 |
| 17:41477756:G:GC | acceptor_gain | 1.0000 |
| 17:41477758:G:C | acceptor_gain | 1.0000 |
| 17:41477758:G:GC | acceptor_gain | 1.0000 |
| 17:41478355:GCTCA:G | donor_loss | 1.0000 |
| 17:41478356:CTCA:C | donor_loss | 1.0000 |
| 17:41478357:TCA:T | donor_loss | 1.0000 |
| 17:41478358:CAC:C | donor_loss | 1.0000 |
| 17:41478360:CCATG:C | donor_gain | 1.0000 |
| 17:41478483:CACT:C | acceptor_gain | 1.0000 |
| 17:41478485:CT:C | acceptor_gain | 1.0000 |
| 17:41478486:TCTGA:T | acceptor_loss | 1.0000 |
AlphaMissense
2767 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 17:41480778:C:G | R107P | 0.996 |
| 17:41479730:C:G | A175P | 0.994 |
| 17:41477557:A:G | I394T | 0.993 |
| 17:41477569:A:G | L390P | 0.991 |
| 17:41477557:A:C | I394S | 0.990 |
| 17:41480775:A:G | L108P | 0.990 |
| 17:41477549:A:G | Y397H | 0.989 |
| 17:41477620:A:G | L373P | 0.988 |
| 17:41477539:A:G | L400P | 0.987 |
| 17:41480712:A:G | I129T | 0.987 |
| 17:41480745:A:G | L118P | 0.987 |
| 17:41480637:A:G | L154P | 0.986 |
| 17:41477549:A:C | Y397D | 0.985 |
| 17:41480775:A:T | L108Q | 0.985 |
| 17:41480784:T:A | N105I | 0.985 |
| 17:41477641:A:G | L366P | 0.984 |
| 17:41480787:A:G | L104P | 0.984 |
| 17:41477545:C:G | R398P | 0.983 |
| 17:41477590:A:G | L383P | 0.983 |
| 17:41477629:C:G | R370P | 0.983 |
| 17:41480763:A:G | L112P | 0.983 |
| 17:41477578:C:G | R387P | 0.982 |
| 17:41479429:A:G | L210P | 0.982 |
| 17:41480751:C:G | R116P | 0.982 |
| 17:41477611:T:G | Q376P | 0.981 |
| 17:41477683:A:G | L352P | 0.981 |
| 17:41480773:C:G | A109P | 0.981 |
| 17:41477559:C:A | E393D | 0.980 |
| 17:41477559:C:G | E393D | 0.980 |
| 17:41477614:C:G | R375P | 0.980 |
dbSNP variants (sampled 300 via entrez): RS1001062970 (17:41477063 C>T), RS1001644174 (17:41479236 G>A,T), RS1002460826 (17:41482352 C>T), RS1002650515 (17:41480434 G>C), RS1002667874 (17:41476994 T>C), RS1003749014 (17:41482007 G>C), RS1004516396 (17:41481719 T>C,G), RS1004672290 (17:41476349 A>G), RS1004724395 (17:41476651 C>T), RS1004973964 (17:41481941 G>A), RS1005385791 (17:41479165 C>T), RS1005463573 (17:41476310 G>A), RS1006397579 (17:41477812 G>A), RS1006500072 (17:41480143 G>A), RS1007171595 (17:41482809 A>G)
Disease associations
OMIM: gene MIM:602764 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
6 total (human), top 6 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| CGP 52608 | affects binding, increases reaction | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Diethylhexyl Phthalate | decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Sodium Selenite | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.